First Wave BioPharma Inc. (FWBI)
2.96
0.13 (4.59%)
At close: May 16, 2024, 8:00 PM
2.96
0.00%
After-hours: May 16, 2024, 04:00 PM EDT
4.59% (1D)
| Bid | 2.93 |
| Market Cap | 5.99M |
| Revenue (ttm) | 138.77K |
| Net Income (ttm) | -6.16M |
| EPS (ttm) | -47.88 |
| PE Ratio (ttm) | -0.061821219715956555 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 3.05 |
| Volume | 56,362 |
| Avg. Volume (20D) | 72,481 |
| Open | 2.93 |
| Previous Close | 2.83 |
| Day's Range | 2.84 - 3.04 |
| 52-Week Range | 2.33 - 60.00 |
| Beta | 1.28 |
About FWBI
First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its product candidates include niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties; and the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients. T...
Industry Biotechnology
Sector Healthcare
IPO Date Oct 11, 2016
Employees 9
Stock Exchange NASDAQ
Ticker Symbol FWBI
Website https://www.firstwavebio.com